Analyst Ratings for Mednax Inc. (MD)Updated: 2017-07-26
Shares of Mednax Inc. (NYSE:MD) have received a consensus rating of Hold from Wall Street analysts. A consensus rating of Hold was previously issued for MD last month.
Of the 14 analysts covering the stock, 2 gave it a buy rating, 0 gave an overweight rating, 11 issued a hold rating, 1 gave an underweight rating, and 0 issued a sell rating. Over the past 90 days, the number of analysts that are bullish on the stock has increased by 0. Meanwhile, the number of analysts pessimistic about the company has increased by 0.
Many analysts weighed in on price targets for MD. The maximum price target given was 68, implying potential capital gains of 20.06 percent. The lowest price target was 53, implying a possible loss of -6.43 percent. It is crucial to not blindly accept any price targets or stock ratings, because many analysts have it in their best interest to give positive coverage of certain stocks.
Analysts have revised their earnings estimates upwards for this quarter, by about 0 percent on average, compared to last month. This can be compared with the average change in earnings estimates over the past 3 months, which is -16.86 percent. On the other hand, earnings estimates for the fiscal year have been revised downwards by -0.72 percent, as compared to a month ago. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes -13.41 percent.
People are often interested in whether analysts were united in the direction of their revisions. Over the past month, 0 analysts increased their quarterly estimates, while 0 analysts revised their estimates downwards. Over the same time period, 0 analysts revised their FY earnings estimates upwards, while 2 analysts decreased their estimates.
Analysts estimate earnings of MD to grow at a rate of -1.81 percent. It's possible to gain additional insight about growth valuation of a company by looking at the PEG ratio. A lower PEG ratio is favorable, because people typically see that as an indicator of higher growth relative to stock price. Many investors consider PEG ratios between 0 and 1 as preferrable, even though it may be more relevant to compare the ratio to that of a firm's competitors. The PEG ratio of MD is -9.31.
MD has traded between a high of 75.83 and a low of 53.80 over the past year. Today's price is 5.28 percent above the 52-week low, and below the high by 25.31 percent. MD has a P/E ratio of 16.86. Investors typically compare the P/E ratio to a company's peers in the industry. The MD value stock report compares MD to some of its peers using value stock charts. The stock has a market capitalization of $5.33 billion. MD will post this quarters earnings in days, on 0000-00-00.